RecruitingNot ApplicableNCT05809401

Pragmatic Assessment and Treatment for the Health System

"Assessment and Treatment of Communicative Pragmatic Abilities in Neurological and Psychiatric Disorders: Feasibility and Clinical Efficacy (PATHS)"

Sponsor

IRCCS San Camillo, Venezia, Italy

Enrollment

330 participants

Start Date

Nov 13, 2019

Study Type

INTERVENTIONAL

Conditions

Traumatic Brain Injury Stroke Schizophrenia

Summary

The project goal is to promote a feasible and effective approach to communicative disorders in neurological and psychiatric populations, focused on the pragmatics of language. Pragmatics allows speakers to use and interpret language in context and to engage in successful communication. Pragmatic language disorder is widespread in clinical conditions and causes reduced social interactions and lower quality of life for both patients and their family. Yet it is seldom considered in assessment and rehabilitation.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing how different groups of people process and communicate, including healthy adults, stroke survivors (with right hemisphere damage), people with traumatic brain injuries, and people with schizophrenia. It aims to improve assessment and treatment approaches. **You may be eligible if...** - You are a healthy adult (no neurological conditions), OR - You have had a single, first-ever stroke affecting the right side of the brain, OR - You have had a traumatic brain injury, OR - You have a diagnosis of schizophrenia - You are willing and able to provide written informed consent in all cases **You may NOT be eligible if...** - You have major conditions that could interfere with test results - You have had more than one stroke, or your stroke affected the left brain hemisphere (for the stroke group) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.